Autopsy report · NCT01200797

SJG-136 in Treating Patients With Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer That Did Not Respond to Previous Treatment With Cisplatin or Carboplatin

“Slow accrual was the reason for study termination.”

The sponsor’s own words in the registry.

Life of this trial

• Registered 2 months after it had already started.
• Ran for about 2 years 7 months before it stopped.
• 19 participants enrolled.
• Results were posted on the registry 2 years 3 months after it ended.

Vital statistics

Status

Terminated

Phase

Phase 2

Sponsor

National Cancer Institute (NCI)

Sponsor type

US National Institutes of Health

Conditions

Recurrent Fallopian Tube Cancer; Recurrent Ovarian Epithelial Cancer; Recurrent Primary Peritoneal Cavity Cancer

Interventions

SJG-136; laboratory biomarker analysis

Participants

19

Sites

6

Countries

United States

Trials that died the same way

• LMB-100 Followed by Pembrolizumab in the Treatment of Adults With Mesothelin-Expressing Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
  “Study was terminated due to slow accrual.” (84% match in meaning)
• Dasatinib for Immune Modulation After Donor Stem Cell Transplant for Hematologic Malignancies
  “Study terminated due to slow accrual.” (82% match in meaning)
• A Study of Plitidepsin in Patients With Relapsed or Refractory Angioimmunoblastic T-cell Lymphoma
  “The main reason that motivated the study termination was the slow recruitment of the trial.” (81% match in meaning)
• Effectiveness of Lumbar Fusion When NanOss Bioactive Is Used With Posterolateral Gutter Fusions
  “Study was terminated due to slow accrual rate.” (81% match in meaning)
• Measuring Relative Afferent Pupillary Defect
  “The study was terminated early for administrative reasons.” (79% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.